OptiPharm Co Ltd banner
O

OptiPharm Co Ltd
KOSDAQ:153710

Watchlist Manager
OptiPharm Co Ltd
KOSDAQ:153710
Watchlist
Price: 4 565 KRW -4.9% Market Closed
Market Cap: ₩67B

Wall St Price Targets

Price Targets Summary
OptiPharm Co Ltd

There are no price targets for OptiPharm Co Ltd.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
OptiPharm Co Ltd Competitors:
Price Targets
FAST
Fastenal Co
-5% Downside
SHLS
Shoals Technologies Group Inc
63% Upside
EBS
Emergent BioSolutions Inc
138% Upside

Revenue
Forecast

5% / Year
Past Growth
-10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss
5% / Year
Past Growth
-10% / Year
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Over the last 9 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is -10%.

Gross Profit
Forecast

2% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
2% / Year
Past Growth
-10% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 9 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is -10%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
14%
Average Beat

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is OptiPharm Co Ltd's stock price target?
Not Available

OptiPharm Co Ltd does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for OptiPharm Co Ltd?
Projected CAGR
-10%

Over the last 9 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 5 years is -10%.

What is the Gross Profit forecast for OptiPharm Co Ltd?
Projected CAGR
-10%

Over the last 9 years, the compound annual growth rate for Gross Profit has been 2%. The projected CAGR for the next 5 years is -10%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett